Clinical course and factors associated with progressive acro-osteolysis in early systemic sclerosis: a retrospective cohort study.
Acro-osteolysis
Cohort study
Hand radiography
Scleroderma and related disorders
Systemic sclerosis
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
01 Mar 2024
01 Mar 2024
Historique:
received:
03
10
2023
accepted:
28
02
2024
medline:
2
3
2024
pubmed:
2
3
2024
entrez:
1
3
2024
Statut:
epublish
Résumé
To examine clinical course of early systemic sclerosis (SSc) and identify factors for progression of acro-osteolysis by a retrospective cohort study. Dual time-point hand radiography was performed at median interval (range 3.0 ± 0.4 years) in 64 recruited patients. Progressive acro-osteolysis was defined as the worsening of severity of acro-osteolysis according to rating scale (normal, mild, moderate, and severe). Incidence of the progression was determined. Cox regression was analyzed for the predictors. A total of 193.6 per 100 person-years, 19/64 patients had progressive acro-osteolysis with incidence of 9.8 per 100-person-years (95% CI 6.3-15.4). The median time of progressive acro-osteolysis was 3.5 years. Rate of progression increased from 1st to 3rd years follow-up with the progression rate at 1-, 2- and 3-years were 0, 2.0 and 18.3%, respectively. Patients with positive anti-topoisomerase I tended to have more progressive acro-osteolysis but no significant predictors on Cox regression. 44%, 18%, and 33% of who had no, mild, and moderate acro-osteolysis previously developed progression and 10 turned to be severe acro-osteolysis. In conclusion, the incidence of progressive acro-osteolysis was uncommon in early SSc but the rate of progression was pronouncedly increasing after three years follow-up. A half of the patients progressed to severe acro-osteolysis.
Identifiants
pubmed: 38429484
doi: 10.1038/s41598-024-55877-x
pii: 10.1038/s41598-024-55877-x
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
5129Informations de copyright
© 2024. The Author(s).
Références
Arana-Ruiz, J. C. & Amezcua-Guerra, L. M. Acro-osteolysis as an indicator of severity in systemic sclerosis. Reumatol. Clín. (Engl. Ed.) 12, 263–266 (2016).
doi: 10.1016/j.reumae.2015.11.010
Barsotti, S. et al. One year in review 2019: Systemic sclerosis. Clin. Exp. Rheumatol. 37, S3-14 (2019).
Sakchaikul, A., Chowchuen, P., Foocharoen, C. & Thammaroj, P. Prevalence and clinical association with acro-osteolysis in early systemic sclerosis. Clin. Exp. Rheumatol. 39, 1093–1098 (2021).
doi: 10.55563/clinexprheumatol/vggbdq
pubmed: 33427611
Van Den Hoogen, F. et al. 2013 classification criteria for systemic sclerosis: An American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum. 65, 2737–2747 (2013).
doi: 10.1002/art.38098
pubmed: 24122180
pmcid: 3930146
LeRoy, E. C. et al. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J. Rheumatol. 15, 202–205 (1988).
pubmed: 3361530
Simonneau, G. et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur. Respir. J. 53, 25 (2019).
doi: 10.1183/13993003.01913-2018
Avouac, J. et al. Radiological hand involvement in systemic sclerosis. Ann. Rheumat. Dis. 65, 1088–1092 (2006).
doi: 10.1136/ard.2005.044602
pubmed: 16414976
pmcid: 1798258
Johnstone, E. M., Hutchinson, C. E., Vail, A., Chevance, A. & Herrick, A. L. Acro-osteolysis in systemic sclerosis is associated with digital ischaemia and severe calcinosis. Rheumatology 51, 2234–2238 (2012).
doi: 10.1093/rheumatology/kes214
pubmed: 22923763
Avouac, J. et al. Predictive factors of hand radiographic lesions in systemic sclerosis: A prospective study. Ann. Rheumat. Dis. 70, 630–633 (2011).
doi: 10.1136/ard.2010.134304
pubmed: 21131648
Steen, V. D. Seminars in Arthritis and Rheumatism 35–42 (Elsevier, 2005).
Jacobsen, S. et al. Clinical features and serum antinuclear antibodies in 230 Danish patients with systemic sclerosis. Brit. J. Rheumatol. 37, 39–45 (1998).
doi: 10.1093/rheumatology/37.1.39
Pokeerbux, M. et al. Survival and prognosis factors in systemic sclerosis: Data of a French multicenter cohort, systematic review, and meta-analysis of the literature. Arthrit. Res. Ther. 21, 1–12 (2019).
doi: 10.1186/s13075-019-1867-1
Koutaissoff, S. et al. Seminars in Arthritis and Rheumatism 455–460 (Elsevier, 2011).
Foocharoen, C. et al. Clinical characteristics and outcomes of 566 Thais with systemic sclerosis: A cohort study. Int. J. Rheumat. Dis. 23, 945–957 (2020).
doi: 10.1111/1756-185X.13859
Foocharoen, C., Peansukwech, U., Pongkulkiat, P., Mahakkanukrauh, A. & Suwannaroj, S. Effect of season on clinical outcomes of Thai systemic sclerosis: Analysis of the Thai national healthcare database. Mod. Rheumatol. 30, 1025–1032 (2020).
doi: 10.1080/14397595.2019.1702238
pubmed: 31813338
Hughes, M. et al. Raynaud phenomenon and digital ulcers in systemic sclerosis. Nat. Rev. Rheumatol. 16, 208–221 (2020).
doi: 10.1038/s41584-020-0386-4
pubmed: 32099191
Maciejewska, M. et al. Raynaud’s phenomenon with focus on systemic sclerosis. J. Clin. Med. 11, 2490 (2022).
doi: 10.3390/jcm11092490
pubmed: 35566614
pmcid: 9105786
Kowal-Bielecka, O. et al. Update of EULAR recommendations for the treatment of systemic sclerosis. Ann. Rheumat. Dis. 76, 1327–1339 (2017).
doi: 10.1136/annrheumdis-2016-209909
pubmed: 27941129